Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AES | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | FAM221A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | PCGF6 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | ZYX | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | DFFB | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | OTUD4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | LRRC75A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | C11orf84 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | TMEM187 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | EMC1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |